Revolution Medicines Inc (RVMD) DEC/2025 Earning Prediction
Revolution Medicines Inc (RVMD) is set to release its DEC/2025 earnings performance on 02/25 16:02:00 ET in After Hours trading. Consensus forecasts predict a revenue of 23.10M and an earnings per share (EPS) of -1.56 for the DEC/2025. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
RVMD Transcript
The earnings call summary shows positive financial performance with a 25% revenue increase and a shift to net income from a loss, which is favorable. However, the lack of strategic updates and the presence of significant risks, such as regulatory hurdles and competitive pressures, balance the positives. The Q&A section did not provide additional insights to alter this view. Without information on market cap, we assume a neutral rating due to mixed signals from financial performance and strategic risks.
RVMD Report
Frequently Asked Questions
What is the Revolution Medicines Inc DEC/2025 Earnings Release Date and Time?
Revolution Medicines Inc (RVMD) is scheduled to release its DEC/2025 earnings report on Feb 25, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Revolution Medicines Inc DEC/2025 Revenue and EPS?
Analysts' consensus predicts 23.10M in revenue and an EPS of -1.56 for Revolution Medicines Inc's DEC/2025.
What Does Intellectia's AI Predict for Revolution Medicines Inc DEC/2025 Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for Revolution Medicines Inc's DEC/2025 earnings, with a prediction date of Feb 25, 2026. Revolution Medicines Inc {summary}
How Can I Use This Earnings Prediction to Trade RVMD Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Feb 25, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Revolution Medicines Inc DEC/2025?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
